Revised FY26 results swing to loss after ERP error correction
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.7 pts more than Nifty Microcap 250 and 5.6 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide has restated FY26 results after an ERP configuration error understated natural gas (raw material) costs by Rs 694.63 lakhs. FY26 PAT swung from a previously reported profit of Rs 130.10 lakhs to a restated loss of Rs 468.16 lakhs. FY26 revenue stood at Rs 28,687.40 lakhs versus Rs 28,971.14 lakhs in FY25. Auditor issued an Unmodified Opinion with Emphasis of Matter. Final dividend of Rs 7 per share retained, subject to AGM approval on Sept 29, 2026. Statutory auditors reappointed for another 5-year term.
Restatement reveals a previously hidden loss, raising concerns over internal controls. Retained dividend and unmodified opinion limit damage, but investor confidence may weaken.